AU3784072A - A process for the preparation of new complexes of biologically active peptides, polypetrides, proteins or derivatives or salts thereof having prolonged and/or increased activity - Google Patents

A process for the preparation of new complexes of biologically active peptides, polypetrides, proteins or derivatives or salts thereof having prolonged and/or increased activity

Info

Publication number
AU3784072A
AU3784072A AU37840/72A AU3784072A AU3784072A AU 3784072 A AU3784072 A AU 3784072A AU 37840/72 A AU37840/72 A AU 37840/72A AU 3784072 A AU3784072 A AU 3784072A AU 3784072 A AU3784072 A AU 3784072A
Authority
AU
Australia
Prior art keywords
polypetrides
prolonged
proteins
derivatives
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU37840/72A
Other languages
English (en)
Inventor
Gyorgy Dr Hajos
Laszlo Dr Szporny
Geza Takacsi Dr Nagy
Gyorgy Dr Fekete
Istvan Dr Gebhardt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richter Gedeon Vegyeszeti Gyar Nyrt
Original Assignee
Richter Gedeon Vegyeszeti Gyar RT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszeti Gyar RT filed Critical Richter Gedeon Vegyeszeti Gyar RT
Publication of AU3784072A publication Critical patent/AU3784072A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/14—Enzymes or microbial cells immobilised on or in an inorganic carrier
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/085—Angiotensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A61K38/35—Corticotropin [ACTH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/52—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Microbiology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
AU37840/72A 1971-01-20 1972-01-12 A process for the preparation of new complexes of biologically active peptides, polypetrides, proteins or derivatives or salts thereof having prolonged and/or increased activity Expired AU3784072A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HURI000418 1971-01-20

Publications (1)

Publication Number Publication Date
AU3784072A true AU3784072A (en) 1973-07-19

Family

ID=11000857

Family Applications (1)

Application Number Title Priority Date Filing Date
AU37840/72A Expired AU3784072A (en) 1971-01-20 1972-01-12 A process for the preparation of new complexes of biologically active peptides, polypetrides, proteins or derivatives or salts thereof having prolonged and/or increased activity

Country Status (10)

Country Link
AU (1) AU3784072A (OSRAM)
BE (1) BE778239A (OSRAM)
CA (1) CA972288A (OSRAM)
DD (1) DD98915A5 (OSRAM)
DE (1) DE2202176A1 (OSRAM)
ES (1) ES399033A1 (OSRAM)
FR (1) FR2122529A1 (OSRAM)
IL (1) IL38546A0 (OSRAM)
NL (1) NL7200716A (OSRAM)
ZA (1) ZA72252B (OSRAM)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS563846B2 (OSRAM) * 1972-10-12 1981-01-27
GB1576376A (en) * 1977-03-30 1980-10-08 Benzon As Alfred Multiple-unit drug dose
DE3230736A1 (de) * 1982-08-18 1984-02-23 Herbert Prof. Dr. 8400 Regensburg Rupprecht An siliciumdioxid als traeger gebundene wirkstoffe, verfahren zu ihrer herstellung und ihre verwendung
DE3502099A1 (de) * 1985-01-23 1986-08-07 Dieter Prof. Dr. Dr. 5883 Kierspe Aderhold Therapeutisches, peptid- und/oder aminosaeurehaltiges mittel
US5130298A (en) * 1989-05-16 1992-07-14 Ethicon, Inc. Stabilized compositions containing epidermal growth factor
FR2799758B1 (fr) * 1999-10-15 2002-05-17 Exsymol Sa Complexe a base d'acide orthosilicique biologiquement assimilable, se presentant sous forme solide, stable et concentree, et procede de preparation

Also Published As

Publication number Publication date
DE2202176A1 (de) 1972-08-03
ZA72252B (en) 1972-09-27
NL7200716A (OSRAM) 1972-07-24
DD98915A5 (OSRAM) 1973-07-12
BE778239A (fr) 1972-05-16
FR2122529B1 (OSRAM) 1975-12-26
ES399033A1 (es) 1975-05-16
FR2122529A1 (en) 1972-09-01
CA972288A (en) 1975-08-05
IL38546A0 (en) 1972-03-28

Similar Documents

Publication Publication Date Title
HU172927B (hu) Sposob poluchenija azolil-/1/-metanov, ikh solej i lechebnykh preparatov soderzhahhikh takoe aktivnoe vehhestvo
SE415660B (sv) Forfarande for framstellning av biologiskt aktiva, berarbundna proteiner
AU462701B2 (en) Polymer biologically active protein complexes
AU3784072A (en) A process for the preparation of new complexes of biologically active peptides, polypetrides, proteins or derivatives or salts thereof having prolonged and/or increased activity
AU467578B2 (en) New cyclic urea derivatives and salts thereof process forthe production thereof and pharmaceutical preparations containing thesame
NL179816C (nl) Werkwijze ter bereiding van een farmaceutisch preparaat met een beta-blokkeringsactiviteit, alsmede de aldus vervaardigde farmaceutische voorwerpen, en werkwijze ter bereiding van nieuwe 5-(2-hydroxy-3-gesubstitueerd amino)propoxy-carbostyril- of 3.4-dihydrocarbostyril-verbindingen of de zouten daarvan.
AU5664073A (en) 5, 9, 13-prostatrienoic acid derivatives and process for their preparation
AU467984B2 (en) Biologically active two-component complexes
CA1029017A (en) Pharmaceutically active new leurosine derivatives and a process for the preparation thereof
AU472380B2 (en) Peptides of acth activity containing aminoxy carboxylic acid on the n-terminal moiety, and a process for the preparation thereof
CA998338A (en) Drug composition having antidiabetic activity
CA957368A (en) Fungicidally active 1,3,4-thiadiazole derivatives
HU172245B (hu) Sposob poluchenija proizvodnykh 1,4-digidro-2h-izokhinolina s osnovnym zamestitelem i lechebnykh preparatov soderzhahhikh takie akyivnye sostavljajuhhie
IL43284A0 (en) New derivatives of 3-amino-5-sulfamoyl-benzoic acid,their manufacture and pharmaceutical preparations containing the
CA1019740A (en) "amino propanediol" derivatives, preparation process and therapeutic applications to humans
GB1408108A (en) Pyrrolylacrylic acids with hypoglycemic activity 4,4-dinitrocarbanilide complexes their preparation and use
AU5033572A (en) Biologically active material
CA1027561A (en) Pharmacologically active 1,4-benzodiazepins and process for their preparation
CA959840A (en) 1,4,2-dioxazine derivatives and preparations
CA941375A (en) 1,2,4-oxidiazole salt, a process for the preparation thereof and pharmaceutical composition comprising same
AU3796472A (en) Biologically active substance
CA867355A (en) Process for the preparation of biologically active polypeptides
AU494797B2 (en) Formuyl alkenoic acids, derivatives thereof and their preparation
CA904317A (en) Pyridinesulfonic acids, process for their manufacture and pharmaceutical preparations containing them
AU480953B2 (en) Amino derivatives of 2, 2-diaryl-cylopropane